G

ood morning, everyone, and how are you today? We are just fine, thank you, especially since a bright, shiny sun is enveloping the serene Pharmalot campus and one of our short people has returned from an overseas sojourn. But enough about distractions. There is much to get done. No doubt, you can relate. On that note, here are some items of interest to help you along. Hope your day is filled with success. And of course, do stay in touch …

Former FDA commissioner Robert Califf believes that drug makers and health care marketers should create a code of ethics to promote truthful and non-misleading uses of medicines for off-label promotion, Medical Marketing & Media says. “I haven’t seen a whole lot of good come from real off-label promotion,” he explained. “Companies are just going to advertise their experiences, and you can look at 100 experiences and pick five that look good.”

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.